Advisory Services Network’s BriaCell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCTX
SM
Advisory Services Network's BCTX Position: Q1 2024 in Review
Advisory Services Network sold out of BriaCell Therapeutics (BCTX) in Q1 2024, closing a stake of 2 shares — an estimated $1.76K sold.
Advisory Services Network first reported a position in BCTX in Q2 2021 and held it in 4 quarters. The position peaked at $24K in Q2 2021. 19 funds tracked by Wall St. Rank hold BCTX as of Q1 2024.
- Advisory Services Network reported no remaining BriaCell Therapeutics position as of Q1 2024 after selling out during the quarter.
- Advisory Services Network sold 2 BriaCell Therapeutics shares in Q1 2024, an estimated $1.76K.
- Advisory Services Network first reported a position in BriaCell Therapeutics in Q2 2021 and held it in 4 quarters.
- Advisory Services Network's BriaCell Therapeutics position peaked at $24K in Q2 2021.
- 19 funds tracked by Wall St. Rank held BriaCell Therapeutics as of Q1 2024.
Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.